Process integration of quality management systems, occupational health and safety, environment in pharmaceutical laboratories: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Published on: 21/12/2023
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Vigilância Sanitária em Debate |
Texto Completo: | https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2182 |
Resumo: | Introduction: Due to health regulations, the quality management system in pharmaceutical companies is compulsory and regularly evaluated by health bodies in relation to GMP supervision. However, health regulation does not extend to concerns about occupational health and safety and the environment. It is important to mature the management systems for these issues. Objective: To study the integration potential of occupational health and safety systems, environment and quality of pharmaceutical laboratories, considering the assumptions, regulatory requirements and particularities of the segment. Method: Exploratory and descriptive study carried out through documentary and field research. Matrixes of requirements of the thematic standards were built and mapped, and actions for integration were proposed. After that, they were submitted to the evaluation by specialists. Results: Comparing the RDC 301/2019 and 652/2022 with the ICH Q10, ISO 9001, 45001 and 14001, it was found that for 71% of the themes and normative requirements, there is synergy and total convergence between the requirements. For the other items, it is necessary to adapt processes and conducts. The propositions listed by the authors to address the gaps were positively validated in relation to achieving implementation feasibility in about 90%. In relation to the positive benefit, the evaluation was unanimous in 100%, and for the implementation of the resources listed, in 66% of the points there is a need for great institutional effort. Conclusions: The integration of a management system that incorporates the themes quality, health and safety and the environment is possible and beneficial for the pharmaceutical industry and supports the definition of strategies, prioritization of actions and allocation of resources. |
id |
FIOCRUZ-9_34dc8f0bd0d2d5e07b3c5f78ad90e04c |
---|---|
oai_identifier_str |
oai:ojs.visaemdebate.incqs.fiocruz.br:article/2182 |
network_acronym_str |
FIOCRUZ-9 |
network_name_str |
Vigilância Sanitária em Debate |
repository_id_str |
|
spelling |
Process integration of quality management systems, occupational health and safety, environment in pharmaceutical laboratories: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Published on: 21/12/2023Integração de processos dos sistemas gestão da qualidade, segurança e saúde ocupacional, meio ambiente em laboratórios farmacêuticos: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Publicado em: 21/12/2023Sistema de Gestão IntegradaIndústria FarmacêuticaQualidade FarmacêuticaIntegrated Management System Pharmaceutical IndustryPharmaceutical QualityIntroduction: Due to health regulations, the quality management system in pharmaceutical companies is compulsory and regularly evaluated by health bodies in relation to GMP supervision. However, health regulation does not extend to concerns about occupational health and safety and the environment. It is important to mature the management systems for these issues. Objective: To study the integration potential of occupational health and safety systems, environment and quality of pharmaceutical laboratories, considering the assumptions, regulatory requirements and particularities of the segment. Method: Exploratory and descriptive study carried out through documentary and field research. Matrixes of requirements of the thematic standards were built and mapped, and actions for integration were proposed. After that, they were submitted to the evaluation by specialists. Results: Comparing the RDC 301/2019 and 652/2022 with the ICH Q10, ISO 9001, 45001 and 14001, it was found that for 71% of the themes and normative requirements, there is synergy and total convergence between the requirements. For the other items, it is necessary to adapt processes and conducts. The propositions listed by the authors to address the gaps were positively validated in relation to achieving implementation feasibility in about 90%. In relation to the positive benefit, the evaluation was unanimous in 100%, and for the implementation of the resources listed, in 66% of the points there is a need for great institutional effort. Conclusions: The integration of a management system that incorporates the themes quality, health and safety and the environment is possible and beneficial for the pharmaceutical industry and supports the definition of strategies, prioritization of actions and allocation of resources.Introdução: Por conta da regulamentação sanitária, o sistema de gestão da qualidade nas indústrias farmacêuticas é compulsório e regularmente avaliado pelos órgãos sanitários com relação à adequação às boas práticas de fabricação (BPF). Entretanto, a regulamentação sanitária não se estende às preocupações com a saúde e segurança ocupacional e com o meio ambiente. É importante amadurecer os sistemas de gestão destas temáticas. Objetivo: Estudar a potencialidade de integração dos sistemas de segurança e saúde ocupacional, meio ambiente e qualidade de laboratórios farmacêuticos levando em consideração as premissas, os requisitos regulatórios e as particularidades do segmento. Método: Estudo exploratório e descritivo realizado por meio de pesquisa documental e de campo. Foram construídas matrizes de correlação de requisitos das normas temáticas, mapeadas e propostas ações para integração e em sequência submetida a avaliação por especialistas. Resultados: Comparando as RDC n° 301/2019 e n° 652/2022 com o ICH Q10, ISO 9001, 45001 e 14001, constatou-se que, para 71% dos temas e requisitos normativos, há sinergia e convergência total entre os requerimentos. Para os demais itens são necessárias adequações de processos e condutas. As proposições elencadas pelos autores para tratar as lacunas foram validadas positivamente com relação ao parâmetro viabilidade de implementação em cerca de 90%. Com relação ao benefício positivo, a avaliação foi unânime em 100% e, para a concretização dos tópicos elencados, para 66% dos pontos há necessidade de grande esforço institucional. Conclusões: A integração de um sistema de gestão que incorpore as temáticas qualidade, saúde e segurança e meio ambiente é possível e benéfica para a indústria farmacêutica e suportaria a definição de estratégias, priorizações de ações e alocação de recursos.Instituto Nacional de Controle de Qualidade em Saúde2023-12-21info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed article""Artículo revisado por pares""Artigo avaliado pelos pares"application/pdfhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/218210.22239/2317-269x.02182Health Surveillance under Debate: Society, Science & Technology ; v. 11 (2023) | Continuous publication; 1-11Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; v. 11 (2023) | Publicación continua; 1-11Vigil Sanit Debate, Rio de Janeiro; v. 11 (2023) | Publicação contínua; 1-112317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2182/1595Copyright (c) 2023 Caroline Mendonça Horato, Jorge Carlos Santos da Costa (Autor)https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMendonça Horato, CarolineCarlos Santos da Costa, Jorge2023-12-21T19:04:43Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/2182Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2023-12-21T19:04:43Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.none.fl_str_mv |
Process integration of quality management systems, occupational health and safety, environment in pharmaceutical laboratories: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Published on: 21/12/2023 Integração de processos dos sistemas gestão da qualidade, segurança e saúde ocupacional, meio ambiente em laboratórios farmacêuticos: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Publicado em: 21/12/2023 |
title |
Process integration of quality management systems, occupational health and safety, environment in pharmaceutical laboratories: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Published on: 21/12/2023 |
spellingShingle |
Process integration of quality management systems, occupational health and safety, environment in pharmaceutical laboratories: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Published on: 21/12/2023 Mendonça Horato, Caroline Sistema de Gestão Integrada Indústria Farmacêutica Qualidade Farmacêutica Integrated Management System Pharmaceutical Industry Pharmaceutical Quality |
title_short |
Process integration of quality management systems, occupational health and safety, environment in pharmaceutical laboratories: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Published on: 21/12/2023 |
title_full |
Process integration of quality management systems, occupational health and safety, environment in pharmaceutical laboratories: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Published on: 21/12/2023 |
title_fullStr |
Process integration of quality management systems, occupational health and safety, environment in pharmaceutical laboratories: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Published on: 21/12/2023 |
title_full_unstemmed |
Process integration of quality management systems, occupational health and safety, environment in pharmaceutical laboratories: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Published on: 21/12/2023 |
title_sort |
Process integration of quality management systems, occupational health and safety, environment in pharmaceutical laboratories: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02182 | Published on: 21/12/2023 |
author |
Mendonça Horato, Caroline |
author_facet |
Mendonça Horato, Caroline Carlos Santos da Costa, Jorge |
author_role |
author |
author2 |
Carlos Santos da Costa, Jorge |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Mendonça Horato, Caroline Carlos Santos da Costa, Jorge |
dc.subject.por.fl_str_mv |
Sistema de Gestão Integrada Indústria Farmacêutica Qualidade Farmacêutica Integrated Management System Pharmaceutical Industry Pharmaceutical Quality |
topic |
Sistema de Gestão Integrada Indústria Farmacêutica Qualidade Farmacêutica Integrated Management System Pharmaceutical Industry Pharmaceutical Quality |
description |
Introduction: Due to health regulations, the quality management system in pharmaceutical companies is compulsory and regularly evaluated by health bodies in relation to GMP supervision. However, health regulation does not extend to concerns about occupational health and safety and the environment. It is important to mature the management systems for these issues. Objective: To study the integration potential of occupational health and safety systems, environment and quality of pharmaceutical laboratories, considering the assumptions, regulatory requirements and particularities of the segment. Method: Exploratory and descriptive study carried out through documentary and field research. Matrixes of requirements of the thematic standards were built and mapped, and actions for integration were proposed. After that, they were submitted to the evaluation by specialists. Results: Comparing the RDC 301/2019 and 652/2022 with the ICH Q10, ISO 9001, 45001 and 14001, it was found that for 71% of the themes and normative requirements, there is synergy and total convergence between the requirements. For the other items, it is necessary to adapt processes and conducts. The propositions listed by the authors to address the gaps were positively validated in relation to achieving implementation feasibility in about 90%. In relation to the positive benefit, the evaluation was unanimous in 100%, and for the implementation of the resources listed, in 66% of the points there is a need for great institutional effort. Conclusions: The integration of a management system that incorporates the themes quality, health and safety and the environment is possible and beneficial for the pharmaceutical industry and supports the definition of strategies, prioritization of actions and allocation of resources. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-12-21 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion "Peer-reviewed article" "Artículo revisado por pares" "Artigo avaliado pelos pares" |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2182 10.22239/2317-269x.02182 |
url |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2182 |
identifier_str_mv |
10.22239/2317-269x.02182 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2182/1595 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2023 Caroline Mendonça Horato, Jorge Carlos Santos da Costa (Autor) https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2023 Caroline Mendonça Horato, Jorge Carlos Santos da Costa (Autor) https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
dc.source.none.fl_str_mv |
Health Surveillance under Debate: Society, Science & Technology ; v. 11 (2023) | Continuous publication; 1-11 Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; v. 11 (2023) | Publicación continua; 1-11 Vigil Sanit Debate, Rio de Janeiro; v. 11 (2023) | Publicação contínua; 1-11 2317-269X reponame:Vigilância Sanitária em Debate instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Vigilância Sanitária em Debate |
collection |
Vigilância Sanitária em Debate |
repository.name.fl_str_mv |
Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br |
_version_ |
1797042047313510400 |